Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat
Kazutaka Kurokohchi(Kagawa University), Shigeki Kuriyama(Kagawa University), Tsutomu Masaki(Kagawa University), Y. Miyauchi, Toshiharu Funaki, Kazuhiko Arima, Makiko Murota, Sharon Watanabe(Institute of Health Economics), Naoki Hosomi, S. Nakai, Shohei Yoshida(Kanazawa University)
Cited by 56
Related Papers
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
|Cell Metabolism|2016|900
Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease
|Nutrients|2018|174
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
|Hepatology Research|2008|142
Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma—A Review
|International Journal of Molecular Sciences|2020|125
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo
|International Journal of Oncology|2014|96